Evidence map›Paper›PMID 2377454›Full record

ArticleNucleic acids research1990

In vitro splicing of fibronectin pre-mRNAs.

P A Norton, R O Hynes

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P A NortonDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.
R O Hynes
Massachusetts Institute of Technology · US

Funding

MECHANISMS OF FIBRONECTIN LOSS FROM TRANSFORMED CELLSF32CA008027 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NORTON, PAMELA A · 1986 to 1988
–
STRUCTURE-FUNCTION RELATIONSHIPS OF FIBRONECTINP01CA026712 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HOUSMAN, DAVID E · 1985 to 1991
–
NCI NIH HHS CA08027NCI NIH HHS CA26712
6 · The paper itself

Abstract

We have investigated the alternative splicing of the EIIIB exon of the rat fibronectin gene. Mini-gene constructs containing this exon and portions of adjacent introns and exons, when transfected into HeLa cells, are transcribed and spliced, but omit the EIIIB exon. In vitro, HeLa nuclear extracts similarly splice out (skip) the EIIIB exon from similarly structured transcripts. Therefore, the HeLa splicing apparatus recognizes as atypical the EIIIB exon and its flanking intron sequences, both in vivo and in vitro. We also report that alterations in the ionic conditions of the in vitro splicing reaction can promote the initiation of EIIIB exon inclusion, as reflected by the formation of intermediate and product RNAs related to the removal of the intron upstream of EIIIB. Processing of this intron correlates with the formation of complexes resembling intermediates in spliceosome assembly. The branch sites involved in this alternative processing pathway are rather distant from the EIIIB 3' splice site, and lie within a region which is well conserved in the fibronectin genes of other species. Thus, the intron upstream of EIIIB shows singular structure and behavior which probably have a bearing on the regulated alternative splicing of this exon.

Indexed as

RNA SplicingAnimalsBase SequenceCloning, MolecularElectrophoresis, Polyacrylamide GelExonsFibronectinsGenesHeLa CellsHumansIntronsMagnesiumMolecular Sequence DataPhylogenyRatsRNA PrecursorsFibronectinsMagnesiumRNA Precursors

Identifiers

PMID2377454
PMCPMC331164
OpenAlexW1986297742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.